John L Locke Jr Charitable Trust is located in Issaquah, WA. The organization was established in 1980. According to its NTEE Classification (E12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Health Care and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. John L Locke Jr Charitable Trust is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2023, John L Locke Jr Charitable Trust generated $721.0k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 8 years, the organization has seen revenues fall by an average of (3.5%) each year. All expenses for the organization totaled $1.1m during the year ending 09/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, John L Locke Jr Charitable Trust has awarded 20 individual grants totaling $6,399,970. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO MAKE CONTRIBUTIONS TO THE JOHN L. LOCKE, JR. CORONARY CARE CENTER OF THE SWEDISH HOSPITAL MEDICAL CENTER IN SEATTLE, WA AND/OR THE JOHN L. LOCKE, JR HEALTH SCIENCES COMPUTER CENTER OF THE UNIV. OF WASHINGTON SCH. OF MEDICINE; AND, IF CONTRIBUTIONS TO EITHER ARE NOT POSSIBLE, THEN TO ANY OTHER CHARITABLE ORGANIZATION TO THE EXTENT THAT IT IS INVOLVED IN THE CARE, TREATMENT AND DIAGNOSIS OF HEART DISEASE AND RESEARCH INTO THE SAME.
Describe the Organization's Program Activity:
Part 3 - Line 4a
GRANT TO THE UNIVERSITY OF WASHINGTON MEDICINE - JOHN L LOCKE JR FUND FOR CARDIAC CARE AND RESEARCH: UTILIZING ARTERIOVENOUS DIFF. TO STUDY ATRIAL CHGS OCCURING IN ATRIAL FIBRILLATION; USING FORTILIN INHIBITORS TO BLOCK ATHEROSCLEROSIS; THE ROLE OF ALTERED LYMPHATIC ENDOTHELIAL CELL PERMEABILITY IN OBESITY; AURORA SCIENTIFIC PERMEABILIZED FIBER SYSTEM EQUIP GRANT TO BETTER ASSESS CARDIAC MUSCLE CONTRACTILITY; MECHANISTIC STUDY OF HEART FAILURE STERILE INFLAMMATION; HIGH-THROUGHPUT FUNCTIONAL CHARACTERISTICS OF MYH7 AND TNNT2; CHRONIC KIDNEY DISEASE IN NEPAL: INTEGRATING CARDIOVASCULAR RISK INTO ECON EVAL FOR PREV AND CONTROL.
GRANTS TO THE SWEDISH MEDICAL CENTER FOUNDATION FOR THE SWEDISH CENTER FUND FOR CARDIAC CARE AND RESEARCH
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Robin J Knepper Chairman/trustee | OfficerTrustee | 1 | $0 |
Lida J Buckner Secretary/trustee | OfficerTrustee | 1 | $0 |
Beth Ness Treasurer/trustee | Trustee | 0.2 | $0 |
Patrick Ryan MD Trustee | Trustee | 0.2 | $0 |
John Petersen II MD Trustee | Trustee | 0.2 | $0 |
Howard Lewis MD Trustee | Trustee | 0.2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $0 |
Investment income | $540,416 |
Tax Exempt Bond Proceeds | $18,284 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $162,296 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $720,996 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,000,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $2,317 |
Fees for services: Accounting | $12,900 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $74,937 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $205 |
Total functional expenses | $1,090,359 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $925,433 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $22,259,009 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $23,184,442 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $19,917,274 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $3,267,168 |
Total liabilities and net assets/fund balances | $23,184,442 |
Over the last fiscal year, John L Locke Jr Charitable Trust has awarded $1,000,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
UNIVERSITY OF WASHINGTON PURPOSE: FUNDING FOR THE CARE, TREATMENT AND DIAGNOSIS OF HEART DISEASE, AND RESEARCH INTO THE SAME. | $500,000 |
SWEDISH MEDICAL CENTER PURPOSE: FUNDING FOR THE CARE, TREATMENT AND DIAGNOSIS OF HEART DISEASE, AND RESEARCH INTO THE SAME. | $500,000 |